Association of Hb F Level With Clinical Severity of Beta Thalassemia

Launched by NANFANG HOSPITAL, SOUTHERN MEDICAL UNIVERSITY · Jun 7, 2021

Keywords

ClinConnect Summary

This clinical trial is studying how the levels of a specific type of hemoglobin, called Hb F, relate to the severity of beta thalassemia, a blood disorder that affects how your body produces hemoglobin. The researchers want to understand if higher levels of Hb F can help lessen the effects of this condition in patients. Beta thalassemia can vary in how it affects people, and this study aims to see if there’s a connection between Hb F levels and how severe the disease is in different patients.

To participate in this trial, individuals must be diagnosed with beta thalassemia. Unfortunately, those with iron deficiency anemia cannot join. If eligible, participants will likely undergo tests to measure their Hb F levels and may provide information about their health. The study is currently looking for individuals of all ages and genders to help advance our understanding of beta thalassemia and potentially improve treatment options in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosed with beta-thalassemia
• Exclusion Criteria:
• • Iron Deficiency Anemia